BIS

ProShares UltraShort NASDAQ Biotechnology

$10.25
+0.00%
Market closed. Last update: 10:54 PM ET

📎 Investment Objective

The BIS ETF seeks to provide daily investment results that correspond to twice the inverse (-2x) of the daily performance of the NASDAQ Biotechnology Index.

Overview

ETF tracking ProShares UltraShort NASDAQ Biotechnology

Category Technology
Issuer ProShares
Inception Date 2010-04-08
Market Cap $1.8M
Average Volume N/A
Dividend Yield 5.87%
52-Week Range $10.19 - $23.85
VWAP $10.24

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The BIS ETF seeks to provide daily investment results that correspond to twice the inverse (-2x) of the daily performance of the NASDAQ Biotechnology Index.

🎯 Investment Strategy

The fund uses swaps and other derivative instruments to achieve its investment objective. It aims to provide leveraged exposure to the inverse performance of the NASDAQ Biotechnology Index on a daily basis.

✨ Key Features

  • Provides -2x daily leveraged exposure to the NASDAQ Biotechnology Index
  • Utilizes swaps and other derivatives to achieve its investment objective
  • Designed for short-term, speculative trading rather than long-term investment
  • Has low assets under management and an expense ratio of 0.00%

⚠️ Primary Risks

  • Significant daily rebalancing risk due to the leveraged nature of the fund
  • Potential for large and unexpected losses if the underlying index moves against the fund's position
  • Lack of long-term performance history makes it difficult to evaluate
  • Low trading volume and assets under management could impact liquidity

👤 Best For

This ETF is intended for experienced, risk-tolerant investors who seek short-term, speculative exposure to the inverse performance of the biotechnology sector. It is not suitable for long-term buy-and-hold investors or those with a low risk tolerance.